Related Experiment Videos
Hemodynamic derangement and cardiac dysfunction in cirrhosis
Paolo Gentilini1, Giorgio La Villa, Giacomo Laffi
1Dipartimento di Medicina Interna, Università degli Studi di Firenze. p.gentilini@dmi.unifi.it
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|August 20, 2004
Summary
Early diuretic use in liver cirrhosis may reverse cardiac dysfunction. This treatment aids in managing fluid balance and improving circulation in patients with advanced liver disease.
Area of Science:
- Hepatology
- Cardiology
- Nephrology
Background:
- Liver cirrhosis is a chronic disease with a long progression, often marked by complications.
- Hemodynamic alterations, including sodium retention and ascites, are key complications in cirrhosis.
- Understanding these hemodynamic changes is crucial for effective disease management.
Purpose of the Study:
- To elucidate the distinct stages of hemodynamic modifications in liver cirrhosis.
- To investigate the impact of early diuretic intervention on cardiac function in cirrhotic patients.
Main Methods:
- The study describes two stages of hemodynamic changes in cirrhosis.
- Focuses on the effects of early administration of diuretics, specifically antialdosteronics.
Main Results:
- The first stage involves water and sodium accumulation, increased plasma flow, vascular instability, and hyperdynamic circulation.
- The second stage is characterized by modified and profoundly altered cardiac function.
- Early diuretic use demonstrated potential to reverse cardiac dysfunction by increasing diuresis and natriuresis and decreasing plasma volume.
Conclusions:
- Hemodynamic modifications in liver cirrhosis progress through identifiable stages.
- Early intervention with diuretics, such as antialdosteronics, can positively impact cardiac function and fluid balance.
- This approach may help restore physiological status in patients with liver cirrhosis and associated complications.